HIMS · Hims & Hers Health Inc
Price
Snapshot
50 fields · last close| Market Cap | $6.53B |
| P/E | 50.87 |
| Float | 209.8M |
| Beta | 2.55 |
| Volatility | 63.7% |
| Exchange | NYSE |
| Sector | Health Care |
| Cap tier | Mid cap |
| Macro sensitivity | Very High |
| Clavix score | 34 |
| Price | 28.68 |
| Change | +2.47% |
| Prev Close | 27.99 |
| Open | 28.86 |
| Day Low | 27.70 |
| Day High | 29.01 |
| Avg Vol | 8 |
| Avg $ Vol | $235.1M |
| 52W High | 65.30 |
| 52W Low | 13.74 |
| 52W Pos | 29.0% |
| From High | −56.08% |
| From Low | +108.73% |
| Max DD 1Y | −76.86% |
| Spread | 0.10% |
| Liquidity | Normal |
| SMA 20 | −1.23% |
| SMA 50 | −5.01% |
| SMA 200 | +2.49% |
| RSI (14) | 45.6 |
| Vol 30D | 72.8% |
| Vol 90D | 87.7% |
| 1Y Range | 14–65 |
| Daily bars | 516 |
| Perf Week | +1.74% |
| Perf Month | −9.97% |
| Perf Quarter | −21.09% |
| Perf Half Y | +15.85% |
| Perf Year | −44.41% |
| Perf YTD | −14.16% |
| Prev Day | +2.47% |
| Clavix | D- |
| Debt / Eq | 1.80 |
| Curr Ratio | 1.90 |
| Int Cover | — |
| FCF Margin | 5.1% |
| Rev Growth | +38.2% |
| Profit | Profitable |
| Leverage | High |
| Sector rank | 46 / 47 |
What HIMS does
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally.
The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.
It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers.
Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services.
Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health.
The company offers its products through retail partnerships, in stores, and online. Hims & Hers Health, Inc. is based in San Francisco, California.
Clavix risk grade
regraded every trading dayHIMS grades D-, 34 of 100. Steadiest on Sector Resilience (72), most exposed on Macro Resilience (20, weak). 1 of the 4 weighted dimensions sit above the Health Care median. Ranks 46 of 47 in Health Care by Clavix score.
How rough the ride is
| HIMS | Health Care median | |
|---|---|---|
| Betavs the overall market · lower is steadier | 2.55 | 0.85 |
| Volatilityannualized | 63.7% | 21.2% |
| Max drawdown, past yearworst peak-to-trough fall | −76.9% | — |
| Typical daily movemedian absolute daily change | 3.17% | — |
| Days beyond ±3%of the last 252 sessions | 13453% | — |
How its days are spread
Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.
52-week range
The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.
Drawdown from the 1-year peak
Percent below the running high over the last 12 months. Zero is a fresh high.
Market sensitivity
| HIMS | Health Care median | |
|---|---|---|
| Beta to the markethow much it swings with the S&P 500 · lower is safer | 2.55 | 0.85 |
| Macro sensitivityrate, dollar and credit exposure bucket | Very High | Moderate55% of 47 |
Where it sits on the macro scale
Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Health Care names sit in each bucket.
Where it ranks in its sector
Rank by Clavix score within the sector. Right is the top of the sector.
Price performance
| HIMS | |
|---|---|
| 1 week | +1.7% |
| 1 month | −10.0% |
| Year to date | −14.2% |
| 1 year | −44.4% |
Context for the rank, not itself a risk measure.
Recent coverage, scored
| HIMS | |
|---|---|
| Articles scoredthe most recent scored coverage, up to 30 | 30since 14 Sep |
| Average score0 most bearish, 100 most bullish | 21 |
| Bullish · bearisharticles above 60 · below 40 | 0 · 30 |
| Directionarticles whose tone is improving vs worsening | 0 ↑ 30 ↓ |
Where the article scores land
Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.
Balance sheet, against the sector
The shaded band is the middle half of the 47 Health Care names Clavix covers; the tick is the sector median.
Growth
| HIMS | |
|---|---|
| Revenue growthyear over year | +38.2% |
Financial Health is shown but does not count toward the grade. Why
0–100, higher is safer. The tick on each bar is the Health Care median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.
Recent news
most recent scored articles · the chip is the article’s score · click to openThe law firm Faruqi & Faruqi is reminding Hims investors who bought shares between August 4, 2025 and July 29, 2026 that they have until November 2, 2026 to apply to be the lead plaintiff in a federal securities class action already filed against the company.
A law firm is telling HIMS investors that a securities class action lawsuit has been filed against Hims & Hers Health on behalf of people who bought the stock between August 4, 2025 and July 29, 2026. Investors have until November 2, 2026 to ask for a leadership role in the case.
A law firm is inviting investors who bought HIMS stock between August 4, 2025 and July 29, 2026 to apply to lead a class action lawsuit against Hims & Hers Health, with a November 2, 2026 deadline.
Rosen Law Firm is reminding Hims & Hers Health (HIMS) investors with losses over $100,000 that they can join a securities class action lawsuit covering shares purchased between August 4, 2025 and July 29, 2026. The deadline to apply to be lead plaintiff is November 2, 2026.
A securities fraud class action lawsuit has been filed against Hims & Hers Health, covering investors who bought HIMS shares between August 4, 2025 and July 29, 2026. The lawsuit alleges the company made materially false or misleading statements about its privacy practices, and investors have until November 2, 2026 to seek lead plaintiff status.
Nearest peers by size
Health Care| Ticker | Company | Grade | Mkt cap | P/E | Beta | |
|---|---|---|---|---|---|---|
| HNGE | Hinge Health Inc | C+ | $7.66B | 70.21 | 1.59 | Compare |
| HSIC | Henry Schein Inc | A- | $9.46B | 23.46 | 0.87 | Compare |
| GKOS | Glaukos Corp | B- | $9.66B | — | 0.74 | Compare |
| PODD | Insulet Corp | C+ | $9.75B | 25.98 | 1.08 | Compare |
| GMED | Globus Medical Inc | B | $9.95B | 18.58 | 1.00 | Compare |
| UHS | Universal Health Services Inc | A- | $10.41B | 6.82 | 1.12 | Compare |
| MOH | Molina Healthcare Inc | B | $10.48B | 22.21 | 0.73 | Compare |
| ALGN | Align Technology Inc | B- | $10.49B | 25.35 | 1.74 | Compare |
You just read one holding. Clavix reads the whole portfolio.
Every position you own, graded on the same five dimensions, with an alert when a grade moves. Three months free on iPhone.